Englewood, CO, United States of America

Viveve, Inc.


USPTO Granted Patents = 7



Forward Citations = 62

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Jonathan B Parmer (5 out of 6 patents)

silverMedal Patrick Karl Howe (3 out of 4 patents)

bronzeMedal Sean Yasuo Sullivan (3 out of 4 patents)

4.  Stanley Levy (3 out of 13 patents)

5.  Steven Marc Lopez (3 out of 4 patents)

6.  Ian F Smith (3 out of 12 patents)

7.  Chun-Chih Cheng (3 out of 3 patents)

8.  Jerome D Jackson (3 out of 50 patents)

9.  Bruce Baldwin Allan (2 out of 3 patents)

10.  Deborah Suzanne Wilkerson (2 out of 2 patents)

11.  Sherree Leigh Lucas (2 out of 2 patents)

12.  Sheree Leigh Lucas (1 out of 1 patent)

13.  David Laurence Black (1 out of 2 patents)

14.  Perry Joseph Tomasetti (1 out of 1 patent)

15.  Stacie Bell (1 out of 3 patents)


7 patents:

Company Overview
Viveve, Inc. is a medical technology company focused on women's intimate health. The company develops clinically proven, non-invasive treatments for conditions such as vaginal laxity and stress urinary incontinence. Viveve's innovative technology delivers long-lasting results with minimal downtime, providing women with safe and effective solutions to improve their quality of life.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Viveve, Inc. USPTO Patent Assignee Logo
7 Patents

#74 in Englewood, CO

#870 in Colorado

#39,929 in US

Englewood, CO (US)
Englewood, CO, United States of America
Forward Citations = 62

15 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viveve, Inc.. Retrieved from https://idiyas.com/company/viveve

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…